Creator: Patrick Connole
Ensign Stresses AIT Strength, Drive for Quality to Wall Streeters

Ensign Group told Wall Streeters that it likes where the company stands, and has the leaders to expand.
Ensign Group (NYSE: ENSG) executives on Nov. 18 told attendees of the 2026 Stephens Annual Investment Conference that the company is in a strong position to continue its stellar growth, reiterating many of the same financial, clinical, and operational successes that it previously announced with its third quarter 2026 earnings report earlier in the month.
The midday reporting on the conference did not sway Ensign’s share price much, if at all, with the overall downtrend in the wider stock market helping to deflate Ensign shares by around 1.5 percent throughout the Wednesday session.
During the talk, Ensign Chair and CEO Barry Port, and Chad Keetch, Ensign chief investment officer, executive vice president and secretary, walked through the most recent numbers, and outlined how the organization, which is built on facility autonomy, intensive administrator-in-training programming, high-quality care, and clustering of properties bodes well for future expansion.
By the Numbers
First, the stats. Ensign reported 17 percent revenue growth, 21.5 percent EBITDA growth, and 24 percent growth in adjusted net income through the first three quarters of the year. The company said its portfolio has grown 20 percent since the start of 2025 via acquisitions and that Ensign added 45 new facilities in 2026.
Quotables
Here are some snippets from the conference presentation:
Raj Kumar, moderator, Stephens: To start, great year from a fundamental perspective for Ensign. . .Although, there have been some external factors that maybe have weighed on the stock, kind of thinking about short reports and acute care volume commentary around surgical volumes. But I would love to get your perspective as you start closing out in 2026. How do you view the operational milestones and results achieved relative to your internal expectations?
Port: Having external noise is always an opportunity, I think, to just sort of self-examine. But it certainly did not change our conviction in the model. It gives us another opportunity, I think, to prove it. And I think you have kind of seen a little bit of how we have decided to present ourselves. I think historically we have made a conscious decision to just sort of be maybe a little bit more private about touting how good we do in one particular area or another, especially when it comes to quality. But at the end of the day, I think that is one of the lessons learned is, we need to tell our story more boldly and more broadly and make sure that we show to the world what our affiliates not only are capable of doing, but what they have done to really transform the industry in a meaningfully positive way. . .I mean, our surveys are 15 percent better than our peers in the states that we operate in. From a Quality Measure standpoint, we are better than the national average on all 15 out of 15 Quality Measures. We are better than our peers by 21 percent when it comes to Quality Measures. Our number of high-performing facilities, that recent designation that CMS came out with, 12 percent of our operations were designated with that high-performing designation, which is almost double of any of our peers that are growing SNF companies. That is something we are proud of and something you will hear us talk a lot more about. Our outcomes are at the heart and the core of why we have been able to achieve the outcomes we have been able to.
Keetch (on real estate): We always would like to remind folks that where we can, we want to own it and operate it. I mean, we are definitely operators first, but throughout the years, we have been able to generate hundreds of millions of dollars of value in the real estate, itself. And if you think about a skilled nursing facility, it sort of is what it is. It is not going to get repurposed into some other use. The value of the underlying real estate is so closely connected to the operations. So, when you take something that is low occupancy, low skilled mix, sometimes even losing money, bad clinical reputation, if you change all those things, that property, the underlying real estate is worth more. So, over time, we have acquired around 200 of our 418 assets are owned.
Most of those, I think, call it two-thirds of them, are completely debt-free and have absolutely no leverage on them at all. There’s lots of things we can do to unlock that, but the one that just kind of stands out is probably the easiest, you can take those assets and go to HUD, for example, and you can get a loan on that, let’s call it 70 percent loan-to-value, using kind of the current market value. If we paid $60,000 a bed for something that’s now worth $200,000 a bed, you can just figure out how you can sort of extract some of that value and put it on the balance sheet in a way to help fund other growth. So, that’s one of many levers that that gives us.
Kumar: As we kind of think about clinical outcomes, clearly, it’s an important part of the story. The team has highlighted it more and more as the quarters progress. How would you characterize that kind of opportunity on still proving the clinical or showcasing the clinical outcomes to, say, managed care partners? When we think about that from an M&A perspective, where these are typically distressed or underperforming facilities that don’t necessarily have the greatest clinical scores. What does that turnaround look like to kind of reach toward Ensign or level or mature level facility KPIs?
Port: I think this probably makes sense to everyone here, but quality is what really drives our economic model. I mean, make no mistake about it, we are in an age where it’s virtually impossible to influence discharge decisions from a hospital by showing up with cute marketing materials and donuts or something like that, right? I mean, they’re financially incentivized, as we are, to drive outcomes. So, readmission rates and lengths of stay really matter to acute hospitals and managed care providers. So, at the core of everything we do as operators, we’re thinking about how to drive that first and foremost.
Kumar: Chad, I think you’ve talked about how you guys are very comfortable with doing 50 to 60 acquisitions annually, but that’s not like a hard target. It’s always based on the opportunity. But maybe talk to the leadership pipeline. Clearly, that’s the most important aspect of driving M&A. What have been the constraints historically, and kind of how Ensign has solved those constraints?
Keetch: As you mentioned, our balance sheet and our availability of capital have never been a constraint for us to do deals, nor has the pipeline, frankly. This year, we’ve announced 45 additional new operations that we’re adding, but we probably evaluated, underwrote, looked at something like 400. Just to give you a sense, if we wanted to double and triple in size, there’s opportunity to do that. The question is, okay, when do you decide to do a deal or not? And the very first question we ask is, who’s going to lead it? Who’s going to be the person that, if this is a broken building clinically, financially, and culturally, it’s going to need a new leader.
I think the thing that is really exciting to us is that there’s a lot of momentum around our story, and we have a lot of folks who really come from other walks of life, different industries, professionals that have done other things, and this is sometimes a second and even a third career opportunity for these folks. Most often, they know somebody who has come to us, and they’ve seen how successful they are and how happy they are. There is a long line of folks that are looking to join and become an administrator-in-training. On average, these are not fresh out of undergrad. . .The average age of an AIT for us is 35 years old, just to give you an idea on that. . .In any given month, we may have a dozen or so folks who have been through multiple levels of interviews who want to become part of the program, and maybe two or three of those get offers. We’re able to be really selective.
Kumar: What do you feel is under the radar as we think about the long-term earnings power of the business? Then, which one of the investments that we’ve gone through today will have the largest impact on driving or capturing that earnings power?
Port: I think it’s probably a combination of the fact that our pipeline of opportunities is, number one, it’s very, very exciting to us. We’re working on a lot of different deals that we feel really, really good about. It’s a mix of turnarounds and also maybe higher performing, but nicer physical plant operations that we might pay a little bit more for. Combined with the fact that, just from an organic standpoint, knowing that almost a quarter of our portfolio is brand new and has just so much organic upside, including those that are in our same-store bucket. I think the fact that there’s so much opportunity in those two things combined gives us a lot of confidence about where we’re headed.
Comments or questions? Contact Patrick Connole at pconnole@parkplacelive.com.

